Phase II study of weekly cabazitaxel for ‘unfit’ metastatic castration resistant prostate cancer patients (mCRPC) progressing after docetaxel (D) treatment. Circulating tumour cell (CTC) analysis (SOGUG-CABASEM Trial)
- Anido, U.
- Fita, M.J.J.
- Munielo-Romay, L.
- Pérez-Valderrama, B.
- Mellado, B.
- de Olza, M.O.
- Calvo, O.F.
- Castellano, D.
- Parra, E.M.F.
- Domenec, M.
- Hernando, S.
- Arija, J.A.
- Caballero, C.
- Duran, I.
- Campayo, M.
- Climent, M.A.
ISSN: 1569-8041, 0923-7534
Année de publication: 2016
Volumen: 27
Pages: vi255
Type: Article